SkinHealth Systems Inc.
SKINNasdaqHealthcare · Surgical & Medical Instruments & Apparatus · DE · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | |
|---|---|---|---|---|---|---|
| Revenue | $300.8M | $334.3M | $398.0M | $365.9M | $260.1M | $119.1M |
| Operating income | −$20.8M | −$67.8M | −$130.9M | −$24.3M | −$36.6M | −$17.2M |
| Net income | −$9.5M | −$29.1M | −$100.1M | $44.4M | −$375.1M | −$29.2M |
| Total assets | $499.8M | $685.7M | $929.1M | $1.01B | $1.22B | $222.8M |
| Total liabilities | $438.7M | $633.9M | $869.7M | $837.4M | $916.5M | $252.8M |
| Equity | $61.1M | $51.8M | $59.4M | $171.5M | $302.3M | −$30.0M |
| EPS (diluted) | $-0.16 | $-0.36 | $-0.76 | $-0.23 | $-3.67 | $-0.85 |
| Shares out. | 125.2M | 123.4M | 132.5M | 150.6M | 54,358 | 35.5M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2025- Operating margin
- −6.9%
- Net margin
- −3.2%
- Return on equity
- −15.6%
- Return on assets
- −1.9%
- Return on capital (ROCE)
- −6.6%
- Liabilities / assets
- 87.8%
- Debt / equity
- 7.19×
- Book value / share
- $0.49
- Revenue growth (YoY)
- −10.0%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2025- Altman Z″ (distress)
- -1.89distress
- Accruals / assets
- −9.4%clean
- Piotroski F-Score
- 6/9mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast. What these scores mean →
Signs
● 2 severe● 4 warning● 2 good- Altman Z″ in the distress zone
- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Operating losses (negative operating margin)
- Reported a net loss
- Revenue declined year-over-year
- High leverage (liabilities > 70% of assets)
- Positive operating cash flow
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Kmissed a reporting deadline ↗Feb 29, 2024
- NT 10-Qmissed a reporting deadline ↗Nov 13, 2023
- NT 10-Qmissed a reporting deadline ↗May 18, 2021
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 16.2M | 9.7 | -1.7% |
| Apr 30, 2026 | 16.5M | 23.1 | +5.6% |
| Apr 15, 2026 | 15.7M | 30.4 | +1.9% |
| Mar 31, 2026 | 15.4M | 22.8 | +0.1% |
| Mar 13, 2026 | 15.3M | 15.5 | -2.0% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Delisting / listing-standard noticeMay 12, 2026
- Results of operationsMay 7, 2026
- Director / officer changeMay 6, 2026
- Director / officer change · Amended charter or bylaws · Regulation FD disclosureApr 22, 2026
- Results of operationsMar 12, 2026
- Other material eventMar 6, 2026
- Results of operationsNov 6, 2025
- Director / officer change · Regulation FD disclosureNov 3, 2025
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- 8-K/AMay 21, 2026
- 144May 20, 2026
- 8-KMay 12, 2026
- SCHEDULE 13D/AMay 11, 2026
- 10-QMay 7, 2026
- 8-KMay 7, 2026
- 8-KMay 6, 2026
- SCHEDULE 13G/AMay 6, 2026
- ARSANNUAL REPORTApr 24, 2026
- DEF 14ADEFINITIVE PROXY STATEMENTApr 24, 2026
- 3FORM 3Apr 22, 2026
- 3FORM 3Apr 22, 2026
- 3FORM 3Apr 22, 2026
- 8-KApr 22, 2026
- SCHEDULE 13GApr 20, 2026
Event-driven situations (4)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.